Press Release Pasithea Therapeutics Announces Presentation of Initial PAS-004 Clinical Data from Ongoing Phase 1/1b Clinical Trial in Adult NF1 Patients at the 2026 European Neurofibromatosis Conference Pasithea · Sep 14
Press Release Department of Energy Mandates Centralia Unit 2 Remain Available for Operation for Additional 90 Days TransAlta Corporation · Sep 14
Press Release Dmitry Shubov Consulting Issues Strategic Market Advisory on Legal Tech AI Pricing Models as Enterprise General Counsels Tighten Diligence Dmitry Shubov Consulting · Sep 14
Press Release Soleo Health Expands Atlanta Footprint With Infusion Centers In Woodstock and Fayetteville, Georgia Soleo Health Holdings, Inc. · Sep 14
Press Release Lyell Immunopharma To Participate in the Baird 2026 Global Healthcare Conference Lyell Immunopharma, Inc · Sep 14
Press Release Pharmazz, Inc. Receives U.S. FDA Orphan Drug Designation for Sovateltide for the Treatment of Neonatal Hypoxic-Ischemic Encephalopathy (NHIE) Pharmazz, Inc. · Sep 14
Press Release Cullinan Therapeutics to Host Virtual Analyst and Investor Event Today to Feature Zipalertinib Plus Chemotherapy Phase 3 REZILIENT3 Data Presented at the IASLC 2026 World Conference on Lung Cancer Cullinan Therapeutics, Inc. · Sep 14
Press Release Immunocore announces achievement of target enrollment in registrational TEBE-AM trial with KIMMTRAK® (tebentafusp) in previously treated advanced melanoma Immunocore Holdings plc · Sep 14
Press Release Slate Medicines Appoints Kenneth Koblan, PhD, as Chief Scientific Officer Slate Medicines · Sep 14
Press Release Physics-informed neural fields enable blind aberration correction for partially coherent quantitative phase imaging Written By: EIN Presswire · Sep 14
Press Release Top Chemical Reactor Manufacturer Advances Integrated Process Equipment Solutions Written By: EIN Presswire · Sep 14
Press Release As Lithium Battery Markets Scale, Americase Experts to Address Safety and Compliance Challenges at LithiumSAFE 2026 Written By: EIN Presswire · Sep 14